2004Unpublished venueRequires access

The Therapy of Cytokine-Induced Killer Cells and its Effects on Immune Functions of the Patients with Malignant Tumor

Hua Dong

Open publisher page 0 citations

Abstract

OBJECTIVE To study the proliferation profile of CIK cells from patient's peripheral blood with different advanced malignant tumors; and assess its effects on immune functions of those patients. METHODSCIK cells were induced from PBMC of 12 tumor patients by in vitro incubation with IL-2?γ-IFN?anti-CD3 monoclonal antibody and IL-1, then were transfused back to those patients;the T cell subgroup and NK cell of patients before and after CIK cell treatment were detected with FCM. RESULT: After 13 days culture, the total number of CIK cells and CD3~(+)CD56~(+)T cells were expanded 123 (range 46~301) and 1 656 (177~5130) times respectively. After being treated with auto-CIK cells, the CD3?CD4?T and NK cells of those patients were increased significantly(P0.01). CONCLISIONCIK cells may be expanded effectively from patients with different malignant tumor;adoptive immunotherapy of auto-CIK cells can significantly enhance cellular immune functions and the side effect is rare, so it is a promising therapy.

About this research paper

What this paper is about

OBJECTIVE To study the proliferation profile of CIK cells from patient's peripheral blood with different advanced malignant tumors; and assess its effects on immune functions of those patients. METHODSCIK cells were induced from PBMC of 12 tumor patients by in vitro incubation with IL-2?γ-IFN?anti-CD3 monoclonal antibody and IL-1, then were transfused back to those patients;the T cell subgroup and NK cell of patients before and after CIK cell treatment were detected with FCM. RESULT: After 13 days culture, the total number of CIK cells and CD3~(+)CD56~(+)T cells were expanded 123 (range 46~301) and 1 656 (177~5130) times respectively. After being treated with auto-CIK cells, the CD3?CD4?T and NK cells of those patients were increased significantly(P0.01). CONCLISIONCIK cells may be expanded effectively from patients with different malignant tumor;adoptive immunotherapy of auto-CIK cells can significantly enhance cellular immune functions and the side effect is rare, so it is a promising therapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To study the proliferation profile of CIK cells from patient's peripheral blood with different advanced malignant tumors; and assess its effects on immune functions of those patients. METHODSCIK cells were induced from PBMC of 12 tumor patients by in vitro incubation with IL-2?γ-IFN?anti-CD3 monoclonal antibody and IL-1, then were transfused back to those patients;the T cell subgroup and NK cell of patients before and after CIK cell treatment were detected with FCM. RESULT: After 13 days culture, the total number of CIK cells and CD3~(+)CD56~(+)T cells were expanded 123 (range 46~301) and 1 656 (177~5130) times respectively. After being treated with auto-CIK cells, the CD3?CD4?T and NK cells of those patients were increased significantly(P0.01). CONCLISIONCIK cells may be expanded effectively from patients with different malignant tumor;adoptive immunotherapy of auto-CIK cells can significantly enhance cellular immune functions and the side effect is rare, so it is a promising therapy.

Key concepts: Cytokine-induced killer cell, Immune system, Peripheral blood mononuclear cell, CD3, Immunotherapy, Monoclonal antibody, Cell therapy, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
The Therapy of Cytokine-Induced Killer Cells and its Effects on Immune Functions of the Patients with Malignant Tumor — Research Paper | ScholarLens